Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells
Open Access
- 1 February 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 27 (2) , 472-480
- https://doi.org/10.1002/hep.510270222
Abstract
Endothelin (ET) peptides have been implicated in the pathogenesis of several biological processes within the liver. ET levels are elevated in the circulation of patients with cirrhosis, and recent data suggest that ET may be overproduced in the liver itself in this condition. The aims of the current study were to elucidate the cellular source and expression of endothelin-1 (ET-1) in normal and injured liver, and to investigate its biological effects on stellate cells, the primary target of ETs in the liver. In normal hepatic cells, preproET-1 messenger RNA (mRNA) was detected in only nonparenchymal cells, predominantly in sinusoidal endothelial cells. After biliary fibrosis and early cirrhosis induced by bile duct ligation, preproET-1 mRNA and immunoreactive ET levels increased with progressive injury in whole liver extracts, as well as in isolated stellate and endothelial cell fractions. Eight days after bile duct ligation, the relative increase in preproET-1 mRNA was 1.6- and 7.6-fold above normal in sinusoidal endothelial and stellate cells, respectively. Additionally, immunoreactive ET peptide levels increased by 60% ± 27% over basal values in sinusoidal endothelial cells and 98% ± 40% in stellate cells. Cultured stellate cells responded dramatically to exogenous ET-1 by the spreading and up-regulation of smooth muscle α actin expression. Furthermore, in early culture before cellular activation, ET-1 (10 nmol/L) caused over a twofold increase in [3H]thymidine incorporation, while activated cells (i.e., those cultured for >1 week) exposed to ET-1 exhibited up to a fivefold decrease in [3H]thymidine incorporation. The data indicate that not only is ET-1 overproduced by both sinusoidal endothelial and stellate cells during liver injury, but that it also has potent effects on features of stellate cell activation. We conclude that autocrine and paracrine production of ET-1 is prominent and is likely to be important in the pathogenesis of hepatic diseases.Keywords
Funding Information
- NIH (to the University of California Liver Center Cell Culture Facility), the Institut National de la Santé et de la Recherche Médicale (INSERM), France (DK 02124, DK 50574, DK 26743)
This publication has 36 references indexed in Scilit:
- Endothelin Induced Contractility of Stellate Cells From Normal and Cirrhotic Rat Liver: Implications for Regulation of Portal Pressure and ResistanceHepatology, 1996
- Endothelin-1 and endothelin-3 in cirrhosis: Relations to systemic and splanchnic haemodynamicsJournal of Hepatology, 1995
- Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neuronsCell, 1994
- Elevated blood pressure and craniofaclal abnormalities in mice deficient in endothelin-1Nature, 1994
- The endothelin system. A new target for therapeutic intervention.Circulation, 1994
- Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.Proceedings of the National Academy of Sciences, 1993
- The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substancesEuropean Journal of Biochemistry, 1993
- Plasma Endothelin Immunoreactivity in Liver Disease and the Hepatorenal SyndromeNew England Journal of Medicine, 1992
- Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients.Journal of Clinical Investigation, 1992
- Molecular characterization of endothelin receptorsTrends in Pharmacological Sciences, 1992